After receiving the ethical approval in Tanzania, NeuroSolve obtained the ethical clearance in Zambia too. The ethical clearance certificate will allow to conduct medical research on Neurocysticercosis also in Zambia.

NeuroSolve is a four-year project funded by the European Commission and EDCTP3, started on May 1, 2023. The African Institutions involved are: University of Dar es Salaam (Tanzania), Sokoine University of Agriculture (Tanzania), University of Zambia (Zambia); the European Institutions are: Universiteit Ghent (Belgium) and R-Evolution Worldwide Srl – Impresa Sociale (Italy), that is also the project Coordinator. NeuroSolve is committed to fight taeniasis/Neurocysticercosis (NCC) disease in Sub-Saharan Africa.

Potrebbe essere un'immagine raffigurante testo

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

50th anniversary of the WHO declaration of malaria-free Italy

On the 50th anniversary of the WHO declaration of malaria-free Italy, national and international institutions engaged in the fight against malaria meet to discuss the contribution of scientific research to

Read More

Third International Conference on Public Health in Africa

The third edition of CPHIA was hosted by the Zambian Ministry of Health and took place from 27th to 30th November 2023 at Mulungushi International Conference Center in Lusaka, Zambia. The topic

Read More

African and European multidisciplinary researchers established an integrated consortium to develop a research project on the dengue and Zika viruses affecting Africa and the world

Dengue and Zika viruses are arboviruses primarily transmitted by Aedes mosquitoes. Dengue and Zika infectious disease frequently erupt in tropical and subtropical regions. Globalization coupled with climate change, significantly expedites their worldwide

Read More